These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14641515)

  • 21. Jaw dystonia triggered by biting into hard food.
    Lagueny A; Caix P; Schuermans P; Julien J
    Mov Disord; 1991; 6(2):174-6. PubMed ID: 2057011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique.
    Guarda-Nardini L; Stecco A; Stecco C; Masiero S; Manfredini D
    Cranio; 2012 Apr; 30(2):95-102. PubMed ID: 22606852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
    Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin in the management of paradoxical activity of jaw muscles.
    Naumann M; Dauphin M; Reichmann H; Reiners K
    J Neurol Neurosurg Psychiatry; 1995 Aug; 59(2):192-3. PubMed ID: 7629541
    [No Abstract]   [Full Text] [Related]  

  • 25. An open-label study of botulinum toxin A for treatment of tardive dystonia.
    Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
    Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory Open Jaw Oromandibular Tardive Dystonia with a Sensory Trick, Treated with Botulinum Toxin: A Case Report.
    Shalash AS; Abushouk AI; Elsherbeny MY; Elrassas H; Kamel T
    Neurol India; 2019; 67(4):1110-1111. PubMed ID: 31512647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Office-based laryngeal injection of botulinum toxin for paradoxical vocal fold motion in a child.
    Montojo J; González R; Hernández E; Zafra M; Plaza G
    Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1161-3. PubMed ID: 26032616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial North American experience with botulinum toxin type A for treatment of anismus.
    Joo JS; Agachan F; Wolff B; Nogueras JJ; Wexner SD
    Dis Colon Rectum; 1996 Oct; 39(10):1107-11. PubMed ID: 8831524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: a randomised, controlled and blinded study.
    Werdelin L; Dalager T; Fuglsang-Frederiksen A; Regeur L; Karlsborg M; Korbo L; Munck O; Winge K
    Clin Neurophysiol; 2011 Nov; 122(11):2305-9. PubMed ID: 21636319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS; Nolan PJ
    J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated high-frequency jaw tremor relieved by botulinum toxin injections.
    Gonzalez-Alegre P; Kelkar P; Rodnitzky RL
    Mov Disord; 2006 Jul; 21(7):1049-50. PubMed ID: 16602105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electromyographic activity of the jaw-closing muscles during jaw opening in patients with masseter muscle contracture.
    Yamaguchi T; Satoh K; Komatsu K; Inoue N; Minowa K; Totsuka Y
    Cranio; 2002 Jan; 20(1):48-54. PubMed ID: 11831344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of mandibular movement trajectories and associated patterns of oral muscle electromyographic activity during spontaneous and apomorphine-induced rhythmic jaw movements in the guinea pig.
    Lambert RW; Goldberg LJ; Chandler SH
    J Neurophysiol; 1986 Feb; 55(2):301-19. PubMed ID: 3950693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tongue, jaw, and lip muscle activity and jaw movement during experimental chewing efforts in man.
    Takada K; Yashiro K; Sorihashi Y; Morimoto T; Sakuda M
    J Dent Res; 1996 Aug; 75(8):1598-606. PubMed ID: 8906129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
    Mantell AM
    Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
    Zhang LD; Liu Q; Zou DR; Yu LF
    Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
    Koman LA; Brashear A; Rosenfeld S; Chambers H; Russman B; Rang M; Root L; Ferrari E; Garcia de Yebenes Prous J; Smith BP; Turkel C; Walcott JM; Molloy PT
    Pediatrics; 2001 Nov; 108(5):1062-71. PubMed ID: 11694682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.